Morningness-Eveningness questionnaire in bipolar disorder.

TitleMorningness-Eveningness questionnaire in bipolar disorder.
Publication TypeJournal Article
Year of Publication2018
AuthorsKanagarajan K, Gou K, Antinora C, Buyukkurt A, Crescenzi O, Beaulieu S, Storch K-F, Mantere O
JournalPsychiatry Res
Volume262
Pagination102-107
Date Published2018 Apr
ISSN1872-7123
Abstract

The Morningness-Eveningness Questionnaire (MEQ) is among the most commonly used scales to measure chronotype. We aimed to evaluate psychometric properties and clinical correlates of MEQ in bipolar disorder. Patients with a clinical diagnosis of bipolar disorder (n = 53) answered questionnaires for chronotype (MEQ), mood (Quick Inventory of Depressive Symptoms-16, Altman Self-Rating Mania Scale), insomnia (Athens Insomnia Scale, AIS), and sleepiness (Epworth Sleepiness Scale). Mood was evaluated using Montgomery-Åsberg Depression Rating Scale and Young Mania Rating Scale. The MEQ showed high internal consistency with Cronbach's alpha of .85. Lower MEQ scores (eveningness) correlated with insomnia (AIS) (r = -.34, p = .013). The estimate for eveningness (13/53, 24.5%) in our study was higher than in comparable studies in the general population. Patients on lithium exhibited a higher mean MEQ score (56.0 on lithium vs 46.9 with no lithium, p = .007), whereas this score was lower for patients on an antidepressant (46.0 on antidepressants vs 52.6 with no antidepressants, p = .023). We conclude that the MEQ score is psychometrically reliable. However, future studies should further evaluate the association of medication with chronotype. Validation of categorical cut-offs for MEQ in a larger sample of bipolar patients is needed to increase clinical utility.

DOI10.1016/j.psychres.2018.02.004
Alternate JournalPsychiatry Res
PubMed ID29427910